Research trends and hotspots of neoadjuvant therapy in pancreatic cancer: a bibliometric analysis based on the Web of Science Core Collection

作者全名:"Wu, Hong-yu; Liu, Tao; Zhong, Tao; Zheng, Si-yuan; Zhai, Qi-long; Du, Chang-jie; Wu, Tian-zhu; Li, Jin-zheng"

作者地址:"[Wu, Hong-yu; Liu, Tao; Zhong, Tao; Zheng, Si-yuan; Zhai, Qi-long; Du, Chang-jie; Wu, Tian-zhu; Li, Jin-zheng] Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, 76 Linjiang Rd, Chongqing 400010, Peoples R China"

通信作者:"Li, JZ (通讯作者),Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, 76 Linjiang Rd, Chongqing 400010, Peoples R China."

来源:CLINICAL AND EXPERIMENTAL MEDICINE

ESI学科分类:CLINICAL MEDICINE

WOS号:WOS:000930714500001

JCR分区:Q2

影响因子:3.2

年份:2023

卷号: 

期号: 

开始页: 

结束页: 

文献类型:Article; Early Access

关键词:Pancreatic cancer; Neoadjuvant therapy; Bibliometric analysis; Hotspot; Web of Science Core Collection

摘要:"Neoadjuvant therapy (NAT) for pancreatic cancer (PC) has achieved certain results. This article was aimed to analyze the trends in NAT in PC over the past 20 years using bibliometric analysis and visualization tools to guide researchers in exploring future research hotspots. Articles related to NAT for PC were retrieved from the Web of Science Core Collection for the period 2002-2021. The information was analyzed and visualized using VOSviewer, Citespace, Microsoft Excel and R software. The number of articles per year has continued to increase over the past 20 years. Of the 1,598 eligible articles, the highest number was from the United States (760), and an analysis of institutions indicated that the University of Texas System (150) had the highest number of articles. Matthew H. G. Katz had the highest number of citations and the highest H-index. ""Pancreatic cancer"" (981), ""Resection"" (623), ""Cancer"" (553), ""Neoadjuvant therapy"" (509) and ""Survival"" (484) were the top five ranked keywords. Combined with the keywords-cluster analysis and citation burst analysis, current research hotspots were the optimal NAT regimen, NAT response assessment, NAT for resectable PC and management of complications. NAT has received increasing attention in the field of PC over the past 20 years, but greater collaboration between countries and additional multicenter randomized clinical trials are needed. Overall, we have revealed current research hotspots and provided valuable information for the choice of future research directions."

基金机构:Joint project of Chongqing Health Commission and Science and Technology Bureau [2022GDRC004]; Kuanren Talents Program of the second affiliated hospital of Chongqing Medical University

基金资助正文:"The work was supported by the Joint project of Chongqing Health Commission and Science and Technology Bureau (NO:2022GDRC004), Kuanren Talents Program of the second affiliated hospital of Chongqing Medical University."